NIHR Biomedical Research Centre, School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
NIHR Biomedical Research Centre, School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Trends Mol Med. 2022 Feb;28(2):143-154. doi: 10.1016/j.molmed.2021.11.004. Epub 2021 Dec 15.
Mycobacterium tuberculosis (Mtb) causes the human disease tuberculosis (TB) and remains the top global infectious pandemic after coronavirus disease 2019 (COVID-19). Furthermore, TB has killed many more humans than any other pathogen, after prolonged coevolution to optimise its pathogenic strategies. Full understanding of fundamental disease processes in humans is necessary to successfully combat this highly successful pathogen. While the importance of immunodeficiency has been long recognised, biologic therapies and unbiased approaches are providing unprecedented insights into the intricacy of the host-pathogen interaction. The nature of a protective response is more complex than previously hypothesised. Here, we integrate recent evidence from human studies and unbiased approaches to consider how Mtb causes human TB and highlight the recurring theme of extracellular matrix (ECM) turnover.
结核分枝杆菌(Mtb)可引起人类结核病(TB),并且在 2019 年冠状病毒病(COVID-19)之后仍然是全球头号传染病大流行。此外,经过长期的共同进化以优化其致病策略,结核分枝杆菌导致的人类死亡人数远远超过任何其他病原体。为了成功对抗这种高度成功的病原体,我们有必要充分了解人类基本疾病过程。虽然免疫缺陷的重要性早已被认识到,但生物疗法和无偏方法正在为宿主-病原体相互作用的复杂性提供前所未有的见解。保护反应的性质比以前假设的要复杂。在这里,我们整合了来自人类研究和无偏方法的最新证据,以探讨 Mtb 如何导致人类 TB,并强调细胞外基质(ECM)周转的反复出现的主题。